Term
| fever, jaundice, dark urine, fatigue, malaise, anorexia, nausea, abdominal discomfort |
|
Definition
|
|
Term
|
Definition
|
|
Term
| leak into blood stream when cells are damaged, can vary over time; Males can have higher levels than women |
|
Definition
|
|
Term
| 0-50 IU/L; found in liver; Men 30 IU/L; women < 19IU/L |
|
Definition
|
|
Term
| 0-45 IUL; found in liver and red cells, cardiac and skeletal muscles; African-American males can have higher levels than Caucasian males |
|
Definition
|
|
Term
|
Definition
| risky if: high INR, low platelets |
|
|
Term
| first to appear in hepatitis A (detectable 5-10 days before symptom onset |
|
Definition
|
|
Term
| appear early in hepatitis A, remains positive for life (life-long protection) |
|
Definition
|
|
Term
| referred to as anti-HAV; + indicates protection |
|
Definition
|
|
Term
| surface antigen in Hepatitis B |
|
Definition
|
|
Term
| immunity (infection or vaccine) in Hepatitis b |
|
Definition
|
|
Term
| sensitive marker of infectious in hep B |
|
Definition
|
|
Term
| envelop (highly infectios) in hep b |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| main screeningsay in hepatitis C serologic tests |
|
Definition
|
|
Term
| time to seroconversion (Anti-HCV) |
|
Definition
|
|
Term
| confirm Ab presence (HCV) |
|
Definition
|
|
Term
| confirmation for a positive test; manual or semi-automated RT-PCR or TMA |
|
Definition
| qualitative viral load (HCV-RNA) |
|
|
Term
| treatment course; manual or semi-automated RT-PCR, bDNA, real-time PCR |
|
Definition
| Quantitative Viral Load (HCV-RNA) |
|
|
Term
| POSITIVE Anti-HCV and POSITIVE HCV RNA |
|
Definition
| acute or chronic depending on clinical context |
|
|
Term
| POSITIVE Anti-HCV and NEGATIVE HCV RNA |
|
Definition
| resolution of HCV or acute HCV during period of low-level viremia |
|
|
Term
| NEGATIVE anti-HCV and POSIIVE HCV RNA |
|
Definition
| early acute HCV or chronic HCV in setting of immunosuppression or false + HCV RNA test |
|
|
Term
| NEGATIVE anti-HCV and NEGATIVE HCV RNA |
|
Definition
|
|
Term
| baseline evaluation in hep c- indicated only for patients with cirrhosis; consider if HIV + |
|
Definition
|
|
Term
| baseline evaluation in hep c- indicated only for patients with cirrhosis; consider if HIV + |
|
Definition
|
|
Term
| follow up for Hepatitis A |
|
Definition
| maybe liver enzymes a few months later |
|
|
Term
| follow up for Hepatitis B |
|
Definition
| ALT and other LFTs; HBV RNA; biopsy; serological markers; renal function for med adjustments |
|
|
Term
| follow up for Hepatitis C |
|
Definition
| ALT and other LFTs; HCV RNA; biopsy; AFP; tests for extra hepatic manifestations; med side effects( i.e. anemia) |
|
|
